How to appeal a UnitedHealthcare diabetes drugs & insulin denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

UnitedHealthcare-specific note: UHC's parent UnitedHealth Group owns Optum (PBM Optum Rx) and Surest. Surest plans have different cost-sharing rules. State complaints flow to state insurance department + DOL/EBSA for self-funded.

What UnitedHealthcare's policy requires for diabetes drugs & insulin

Cited policy: OptumRx Insulin Analog Step Therapy — UHC Commercial PDL

Trial/failure of preferred basal (Basaglar or Semglee) ≥30 days, or documented contraindication. T1D and pregnancy auto-bypass.

How UnitedHealthcare denies diabetes drugs & insulin — and how to counter it

Where UnitedHealthcare pushes back: 1) Member has not tried preferred basal insulin; 2) No documentation of intolerance to biosimilar.

Counter-arguments that hold up: Cite DEVOTE NEJM 2017 severe-hypo reduction with degludec. Document prior NPH/glargine hypo events. ADA 2025 §9.5 analog preference. T1D or pregnant → cite auto-bypass clause.

What UnitedHealthcare typically denies for diabetes drugs & insulin

Across UnitedHealthcare's commercial and Medicare books, denials cluster around a small number of patterns. For diabetes drugs & insulin, expect:

• GLP-1 weight-loss exclusion
• Out-of-network reduction citing UCR
• Step therapy on biologics
• Prior auth denied for advanced imaging
• Quantity limits on specialty drugs

Treatments most often denied in this category

These are the diabetes drugs & insulin treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Rapid-acting analog insulin
• Basal analog insulin
• Pre-mixed insulin
• Concentrated insulin
• GLP-1 for T2D
• DPP-4 inhibitor

How to submit the appeal to UnitedHealthcare

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document UnitedHealthcare cited in the denial.
3. File the appeal through UnitedHealthcare's portal (members: https://www.myuhc.com ; providers: https://www.uhcprovider.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In MN, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See UnitedHealthcare's prior-authorization criteria by drug: UnitedHealthcare PA criteria on ApprovalHelp.